News
Timely earnings analysis, material updates, and thesis changes from our AI ensemble. Ticker-specific, evidence-grounded, updated as events unfold.
An Update on Equity Coverage: Moving to a Leaner, Curated Model
The equity engine isn't shutting down — but it's changing shape. Running a multi-model ensemble across a large coverage universe is no longer economically sustainable at volume, so equity coverage is moving to a curated model: a focused set of names under active analysis, and an iceblock of paused-but-published analyses. New updates resume mid-June 2026.
COMP Q1 2026: $61M EBITDA Above Guide, Year-1 Synergy Target Raised to $300M, Credit Ratings Upgraded — Thesis to Price-Below-Value
First combined post-merger quarter: Adj. EBITDA $61M ($42M ex one-time LTIP) vs. $15-35M guide; first GAAP-positive quarter ($22M, aided by $401M one-time deferred tax benefit). Year-1 synergy actioned target raised to $300M (4th consecutive raise); 3-year to $500M; $250M+ already actioned in 82 days. Moody's B2 / S&P B+ initiated April 2026, both POSITIVE outlook, both upgrades vs. Anywhere standalone. Two markets resolved (avg Brier 0.017): comp-q1-2026-combined-ebitda → NO (correctly anticipated), comp-2026-year1-synergies → YES early. Six within-band signal softenings; Stress Scanner STRAINED minority untenable; Moat Mapper trajectory upgraded to Positive. Thesis classification upgrades from price-at-value to price-below-value at $8.61.
Robinhood Q1 2026: Crypto Reverts as Predicted, but NII Strength + Rothera Vertical Broaden the Moat Surface
Robinhood reported Q1 2026 revenue of $1.07B (+15% YoY), diluted EPS of $0.38 (+3%), and adjusted EBITDA margin of 50% — the first sequential AND YoY margin compression in the tracked period. The cross-lens synthesis (seven lenses re-evaluated) is MATERIAL, directionally MIXED, and label-stable: zero baseline signal labels changed; seven new labels established from four lenses that did not run in baseline. Crypto -47% YoY confirmed cycle reversion as predicted, with Bitstamp $42B Q1 institutional volume providing structural-floor evidence. The biggest positive surprise: net interest revenue +24% YoY despite rate cuts, margin book +93% YoY — the 'natural hedge' is materially closer to proven. The biggest new conditioning factor: operating-leverage regime shift as the 'harvest-mode' narrative is paused for reinvestment into Trump Accounts, Rothera, Banking, and Cortex. Stress Scanner and Consolidation Calibrator independently confirm FUNDING_FRAGILITY=STABLE and CAPITAL_DEPLOYMENT=DISCIPLINED. Sector Scrutinizer positions HOOD as fintech CONTENDER with POSITIVE_DIVERGENCE on innovation velocity. Thesis classification holds at price-at-value, MEDIUM-HIGH confidence (raised from MEDIUM on cross-lens corroboration).
Visa FY26 Q2: VAS Hits 30% of Net Revenue, Triggering Durability Upgrade
Visa delivered the strongest non-Visa-Europe / ex-pandemic print since 2013: net revenue +17% nominal / +16% cc, VAS at 30% of net revenue (+27% cc), cross-border ex-Europe +11% cc for a second consecutive quarter, and the client incentive ratio improved to 27.4%. Two simultaneous trip wires resolved favorably in a single print — VAS share crossed the 25% de-escalation threshold, and cross-border did NOT trigger the <+10% escalation. The signal upgrade follows: REVENUE_DURABILITY moves from CONDITIONAL to DURABLE, the only band-level change in this update. The litigation reserve drawdown of $4.4B (combined accrued + escrow, $6.0B → $1.6B) retroactively validates the FY2025 reserve build as settlement funding, retiring one specific bear data point. One prediction market resolved YES (VAS revenue share >25% in any FY26 quarter, Brier 0.053). Two new strategic pillars — stablecoin (160 card programs, $7B settlement run-rate +50% QoQ) and AI/agentic commerce (Visa LLM, Intelligent Commerce Connect, Visa CLI POC) — reposition Visa defensively against tail catalysts. CCCA / DOJ silence — regulatory tail unchanged. Stock at $328.99 (+6.4% from pre-call $309.30); thesis classification holds at price-below-value, MEDIUM confidence — operational pillar materially strengthened, regulatory pillar unchanged.
AMZN Q1 2026: AWS Reaccelerates +28%, Trainium Tops $225B Commitments — Thesis Upgrades to Mispriced-Bullish
Amazon delivered the most thesis-validating single quarter in this analysis's modeled history: AWS reaccelerated to +28% YoY (fastest in 15 quarters; +480bps from Q4'25), AWS operating margin stepped 270bps sequentially to ~37.8% while absorbing $43.2B of Q1 cash capex, and AWS remaining performance obligations printed $364B (+49% sequential) plus a separately disclosed >$100B Anthropic 5GW commitment plus $225B cumulative Trainium commitments. The primary cross-lens de-escalation trigger (AWS backlog >$300B by Q2 2026) resolved YES at the first observable with a 21% margin of safety (Brier 0.2025). Five signal moves: CAPITAL_DEPLOYMENT QUESTIONABLE → MIXED, NARRATIVE_REALITY_GAP DIVERGING → ALIGNED, EXPECTATIONS_PRICED DEMANDING → REASONABLE, plus establishing UNIT_ECONOMICS PROVEN and OPERATIONAL_EXECUTION EXCEEDING. Stock at $257.25 (+22% from Feb 9 baseline; -1.46% pre-print). Thesis classification upgrades from price-at-value to mispriced-bullish at HIGH confidence.
Alphabet Q1 2026: Cloud Backlog Doubles to $462B, but Capital Allocation Pivots to Debt-Funded CapEx
Alphabet delivered a MATERIAL Q1 2026 print with one signal change (ACCOUNTING_INTEGRITY: CLEAN to NUANCED) and significant evidence rotation across five other signals — yet the disposition holds at price-at-value. Search reaccelerated to +19% YoY with AI Mode credited as expansionary; Google Cloud printed +63% with operating margin stepping to 32.9%; contracted backlog nearly doubled to $462B; Subscriptions reached 350M; GenAI revenue +800% YoY. Simultaneously the cost side escalated: D&A accelerated to +44% YoY (vs +38% FY25 baseline), FY26 capex was raised to $180-190B, FY27 telegraphed 'significantly higher,' $31.1B of senior notes were issued, Q1 buybacks went to zero, and net cash compressed by $25B in one quarter. One prediction market resolves: YouTube ads sub-10% bi-conditional NO at Brier 0.0729. Stock at $374.62 (+7.9% post-print) absorbed the demand validation more aggressively than the cost escalation; thesis classification holds at price-at-value, MEDIUM confidence.
MSFT Q3 FY26: Two Markets Resolve YES, but Q4 Cloud GM Guide Breaks the Stabilization Path
Microsoft delivered a net thesis-confirming Q3 FY26 print: Azure +39% cc beat the +37-38% guide and Microsoft Cloud gross margin landed at 66% versus the 65% guide — two prediction markets resolved YES (Brier 0.116 / 0.194). M365 Copilot crossed 20M+ paid seats; AI ARR hit $37B at +123% YoY. The bear thesis sharpened on observables: CY26 capex guide raised to $190B (third upward revision in 12 months), Q4 FY26 Cloud GM guide stepped down to 64% (breaking the 65%+ for 2-quarter bull-case stabilization path), and a second consecutive Activision-era gaming impairment landed in MPC opex. Stock fell 4.4% to $405.79; multiple compresses to ~26-27x adjusted FY26 P/E. Thesis classification holds at price-at-value, MEDIUM-HIGH confidence.
AMKR Q1 2026: Beat-and-Raise Compresses the Earnings Valley as Stock Rallies 60%
Amkor Technology reported Q1 2026 revenue of $1.685B (+27% YoY), gross margin of 14.2% (above the 12.5%-13.5% guide), and diluted EPS of $0.33 (above the $0.28 high end of guidance). Q2 guide is $1.75B-$1.85B revenue, 14.5%-15.5% GM, and $0.42-$0.52 EPS. All four end markets grew YoY (Communications +42%, Auto/Industrial +28%, Computing +19%, Consumer +4%). Debt/EBITDA fell to 1.1x; the Board authorized a $300M buyback on 4/23. Two prediction markets resolved YES (Q1 EPS beat, Brier 0.19; H1 GM >14%, Brier 0.61 — flagged as the largest miscalibration in the set). The stock has rallied ~60% from $44.45 to $71.33; thesis stays price-at-value with the asymmetry now narrowed.
BE Q1 2026: Beat-and-Raise Validates Operating Leverage, Brookfield Channel Hits 49.7%
Bloom Energy reported Q1 2026 revenue of $751M (+130% YoY, product +208%), non-GAAP operating margin of 17.3% (+1,330bps YoY), and adjusted EBITDA of $143M. FY2026 guidance was raised across the board: revenue to $3.4-$3.8B, non-GAAP operating income to $600-$750M (4.8x lift at midpoint), EPS guide newly introduced at $1.85-$2.25. Simon Edwards appointed permanent CFO. Four of seven Round 1 markets resolved: operating margin >10% YES, permanent CFO YES, related-party revenue <30% NO (came in at 49.7%), service margin >=20% NO (13.3% GAAP / 18.0% non-GAAP). Stock rallied from $160 at the March analysis to $226 (+41%). Price-above-value classification holds with composition shifting from execution risk to priced-in perfection plus structural counterparty concentration.
BKNG Q1 2026: Take Rate Holds at 10.28%, Six Quarters Post-DMA With No Compression
Booking Holdings reported Q1 2026 revenue of $5.532B (+16% reported, +10% CC), gross bookings $53.8B, and adjusted EBITDA $1.290B (+19%) with margin expanding 40bps to 23.3%. Accommodation take rate held at 10.28% versus 10.20% a year ago — six consecutive quarters of stability following the November 2024 DMA parity-clause ban. Free cash flow $3.108B; $3.6B repurchased in Q1. The 25-for-1 stock split effected April 2 puts the share at $173.32. Zero markets resolved — all eight active markets need future-quarter or external data. CONFIRMATION update; price-below-value classification holds at MEDIUM confidence.
BRO Q1 2026: Organic Flat at 0.0% Resolves NO, Margin and $250M Buyback Hold the Floor
Brown & Brown reported Q1 2026 revenue of $1.9B (+35.4%), Adjusted EBITDAC margin 38.5% (+40 bps YoY), Adjusted EPS $1.39 (+7.8%), and operating cash flow $262M (+23%). Organic Revenue grew 0.0% — well below the 3.0% market threshold (resolved NO at Brier 0.270) and below management's 'modest improvement over 2.8%' guide. Management deployed $250M in share repurchases — half of the FY26 $500M market threshold in a single quarter. Howden cumulative attrition reached ~$33M against the $50M threshold. Thesis classification stays price-below-value MEDIUM; conviction reduced.
CNC Q1 2026: Beat-and-Raise — HBR 87.3%, EPS $3.37, FY Guide Lifted to $3.40
Centene reported Q1 2026 consolidated HBR of 87.3% (270bps below the 90% bear-case threshold), adjusted EPS of $3.37 in a single quarter (already above the original FY guide of >=$3.00), and $4.4B operating cash flow that funded $1B of senior-note paydown. Management raised FY2026 adjusted EPS guidance from >=$3.00 to >=$3.40 and added $1B to revenue guidance. The Q1 HBR market resolved YES (Brier 0.34 against the 0.42 ensemble). Stock rerated +42% from $34.89 to $49.56 — the recovery is now priced. Thesis classification holds price-at-value MEDIUM, but the central uncertainty has shifted from 'will the recovery happen' to 'how durable is it through 2027.'